Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Predicting Pre-transplant Abstinence in Patients with Alcohol-Induced Liver Disease.

Gong A, Leitold S, Uhanova J, Dolovich C, Medd P, Peretz D, Minuk G.

Clin Invest Med. 2018 Jun 30;41(2):E37-E42. doi: 10.25011/cim.v41i2.29913.

PMID:
29959881
2.

Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis.

Minuk GY, Iliant V, Zhou N, Kaita KD, Wong SG, Peretz D, Uhanova J.

Liver Int. 2018 Jun;38(6):1110-1116. doi: 10.1111/liv.13644. Epub 2017 Dec 15.

PMID:
29193593
3.

Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts.

Herder C, de Las Heras Gala T, Carstensen-Kirberg M, Huth C, Zierer A, Wahl S, Sudduth-Klinger J, Kuulasmaa K, Peretz D, Ligthart S, Bongaerts BWC, Dehghan A, Ikram MA, Jula A, Kee F, Pietilä A, Saarela O, Zeller T, Blankenberg S, Meisinger C, Peters A, Roden M, Salomaa V, Koenig W, Thorand B.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1222-1227. doi: 10.1161/ATVBAHA.117.309307. Epub 2017 Apr 20. Review.

PMID:
28428221
4.

Determining the cost of implementing and operating a remote patient monitoring programme for the elderly with chronic conditions: A systematic review of economic evaluations.

Peretz D, Arnaert A, Ponzoni NN.

J Telemed Telecare. 2018 Jan;24(1):13-21. doi: 10.1177/1357633X16669239. Epub 2016 Sep 19. Review.

PMID:
27650163
5.

First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases.

Aravinthan AD, Doyle AC, Issachar A, Dib M, Peretz D, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Greig PD, Grant DR, Selzner N, Lilly LB, Renner EL.

Am J Transplant. 2016 Dec;16(12):3512-3521. doi: 10.1111/ajt.13828. Epub 2016 May 23.

6.

Predicting propulsive forces using distributed sensors in a compliant, high DOF, robotic fin.

Kahn JC Jr, Peretz DJ, Tangorra JL.

Bioinspir Biomim. 2015 May 18;10(3):036009. doi: 10.1088/1748-3190/10/3/036009.

PMID:
25985056
7.

New optical method for enhanced detection of colon cancer by capsule endoscopy.

Ankri R, Peretz D, Motiei M, Sella-Tavor O, Popovtzer R.

Nanoscale. 2013 Oct 21;5(20):9806-11. doi: 10.1039/c3nr02396f.

PMID:
23969635
8.

Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein.

Sigurdson CJ, Joshi-Barr S, Bett C, Winson O, Manco G, Schwarz P, Rülicke T, Nilsson KP, Margalith I, Raeber A, Peretz D, Hornemann S, Wüthrich K, Aguzzi A.

J Neurosci. 2011 Sep 28;31(39):13840-7. doi: 10.1523/JNEUROSCI.3504-11.2011.

9.

A universal method for detection of amyloidogenic misfolded proteins.

Yam AY, Wang X, Gao CM, Connolly MD, Zuckermann RN, Bleu T, Hall J, Fedynyshyn JP, Allauzen S, Peretz D, Salisbury CM.

Biochemistry. 2011 May 24;50(20):4322-9. doi: 10.1021/bi200215j. Epub 2011 May 3.

PMID:
21539296
10.

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease.

Gao CM, Yam AY, Wang X, Magdangal E, Salisbury C, Peretz D, Zuckermann RN, Connolly MD, Hansson O, Minthon L, Zetterberg H, Blennow K, Fedynyshyn JP, Allauzen S.

PLoS One. 2010 Dec 30;5(12):e15725. doi: 10.1371/journal.pone.0015725.

11.

Atypical prion protein conformation in familial prion disease with PRNP P105T mutation.

Polymenidou M, Prokop S, Jung HH, Hewer E, Peretz D, Moos R, Tolnay M, Aguzzi A.

Brain Pathol. 2011 Mar;21(2):209-14. doi: 10.1111/j.1750-3639.2010.00439.x. Epub 2010 Sep 28.

PMID:
20875062
12.

The octarepeat region of the prion protein is conformationally altered in PrP(Sc).

Yam AY, Gao CM, Wang X, Wu P, Peretz D.

PLoS One. 2010 Feb 24;5(2):e9316. doi: 10.1371/journal.pone.0009316.

13.

Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation.

Giles K, Glidden DV, Beckwith R, Seoanes R, Peretz D, DeArmond SJ, Prusiner SB.

PLoS Pathog. 2008 Nov;4(11):e1000206. doi: 10.1371/journal.ppat.1000206. Epub 2008 Nov 14.

14.

Factors associated with time to laparoscopic cholecystectomy for acute cholecystitis.

Daniak CN, Peretz D, Fine JM, Wang Y, Meinke AK, Hale WB.

World J Gastroenterol. 2008 Feb 21;14(7):1084-90.

15.

Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.

Lau AL, Yam AY, Michelitsch MM, Wang X, Gao C, Goodson RJ, Shimizu R, Timoteo G, Hall J, Medina-Selby A, Coit D, McCoin C, Phelps B, Wu P, Hu C, Chien D, Peretz D.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11551-6. Epub 2007 Jun 29.

16.

Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.

Karpuj MV, Giles K, Gelibter-Niv S, Scott MR, Lingappa VR, Szoka FC, Peretz D, Denetclaw W, Prusiner SB.

Mol Med. 2007 Mar-Apr;13(3-4):190-8.

17.

Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB.

Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19105-10. Epub 2006 Dec 1.

18.

Inactivation of prions by acidic sodium dodecyl sulfate.

Peretz D, Supattapone S, Giles K, Vergara J, Freyman Y, Lessard P, Safar JG, Glidden DV, McCulloch C, Nguyen HO, Scott M, Dearmond SJ, Prusiner SB.

J Virol. 2006 Jan;80(1):322-31.

19.

Transmission barriers for bovine, ovine, and human prions in transgenic mice.

Scott MR, Peretz D, Nguyen HO, Dearmond SJ, Prusiner SB.

J Virol. 2005 May;79(9):5259-71.

20.

Trafficking of prion proteins through a caveolae-mediated endosomal pathway.

Peters PJ, Mironov A Jr, Peretz D, van Donselaar E, Leclerc E, Erpel S, DeArmond SJ, Burton DR, Williamson RA, Vey M, Prusiner SB.

J Cell Biol. 2003 Aug 18;162(4):703-17.

21.

Differential inhibition of prion propagation by enantiomers of quinacrine.

Ryou C, Legname G, Peretz D, Craig JC, Baldwin MA, Prusiner SB.

Lab Invest. 2003 Jun;83(6):837-43.

PMID:
12808118
22.

Pseudo-iatrogenic hypospadias: the megameatus intact-prepuce hypospadias variant.

Peretz D, Westreich M.

Plast Reconstr Surg. 2003 Mar;111(3):1182-5.

PMID:
12621189
23.

Conformation of PrP(C) on the cell surface as probed by antibodies.

Leclerc E, Peretz D, Ball H, Solforosi L, Legname G, Safar J, Serban A, Prusiner SB, Burton DR, Williamson RA.

J Mol Biol. 2003 Feb 14;326(2):475-83.

PMID:
12559915
24.

Moxibustion.

Peretz DI.

CMAJ. 2002 Sep 3;167(5):448; author reply 448. No abstract available.

25.

A change in the conformation of prions accompanies the emergence of a new prion strain.

Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB, Scott MR.

Neuron. 2002 Jun 13;34(6):921-32.

26.

Prions in skeletal muscle.

Bosque PJ, Ryou C, Telling G, Peretz D, Legname G, DeArmond SJ, Prusiner SB.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3812-7.

27.

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.

Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB.

Nature. 2001 Aug 16;412(6848):739-43.

PMID:
11507642
28.

Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH.

Matsunaga Y, Peretz D, Williamson A, Burton D, Mehlhorn I, Groth D, Cohen FE, Prusiner SB, Baldwin MA.

Proteins. 2001 Aug 1;44(2):110-8.

PMID:
11391773
29.

Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Leclerc E, Peretz D, Ball H, Sakurai H, Legname G, Serban A, Prusiner SB, Burton DR, Williamson RA.

EMBO J. 2001 Apr 2;20(7):1547-54.

30.

Strain-specified relative conformational stability of the scrapie prion protein.

Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, Prusiner SB.

Protein Sci. 2001 Apr;10(4):854-63.

31.

Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.

Supattapone S, Bosque P, Muramoto T, Wille H, Aagaard C, Peretz D, Nguyen HO, Heinrich C, Torchia M, Safar J, Cohen FE, DeArmond SJ, Prusiner SB, Scott M.

Cell. 1999 Mar 19;96(6):869-78.

32.

Mapping the prion protein using recombinant antibodies.

Williamson RA, Peretz D, Pinilla C, Ball H, Bastidas RB, Rozenshteyn R, Houghten RA, Prusiner SB, Burton DR.

J Virol. 1998 Nov;72(11):9413-8.

33.

Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system.

Blochberger TC, Cooper C, Peretz D, Tatzelt J, Griffith OH, Baldwin MA, Prusiner SB.

Protein Eng. 1997 Dec;10(12):1465-73.

PMID:
9543009
34.

A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform.

Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, Rozenshteyn R, James TL, Houghten RA, Cohen FE, Prusiner SB, Burton DR.

J Mol Biol. 1997 Oct 31;273(3):614-22.

PMID:
9356250
35.

Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.

Williamson RA, Peretz D, Smorodinsky N, Bastidas R, Serban H, Mehlhorn I, DeArmond SJ, Prusiner SB, Burton DR.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7279-82.

36.

Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.

Kaneko K, Peretz D, Pan KM, Blochberger TC, Wille H, Gabizon R, Griffith OH, Cohen FE, Baldwin MA, Prusiner SB.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11160-4.

37.

[Treatment of patients with myocardial infarct: consensus report-- revision of the 1991 guidelines issued by the Canadian Society of Cardiology].

Fallen EL, Cairns J, Dafoe W, Frasure-Smith N, Genest J Jr, Massel D, Peretz D, Tremblay GJ, Williams WL.

Can J Cardiol. 1995 Sep;11(8):659-69. Review. French. No abstract available.

PMID:
7671175
38.

Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines.

Fallen EL, Cairns J, Dafoe W, Frasure-Smith N, Genest J Jr, Massel D, Peretz D, Tremblay GJ, Williams WL.

Can J Cardiol. 1995 Jun;11(6):477-86. Review. No abstract available.

PMID:
7780868
40.

Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity.

Peretz D, Gitay-Goren H, Safran M, Kimmel N, Gospodarowicz D, Neufeld G.

Biochem Biophys Res Commun. 1992 Feb 14;182(3):1340-7.

PMID:
1540178
41.

Report of the Canadian Cardiovascular Society's consensus conference on the Management of the Postmyocardial Infarction Patient.

Fallen EL, Armstrong P, Cairns J, Dafoe W, Frasure-Smith N, Langer A, Massel D, Oldridge N, Peretz D, Tremblay GJ, et al.

CMAJ. 1991 Apr 15;144(8):1015-25. Review.

42.

[Posterior approach for excision of sacral chordoma].

Waisman M, Erde M, Bernfeld B, Peretz D.

Harefuah. 1990 Aug;119(3-4):70-2. Hebrew.

PMID:
2227671
43.
44.
45.

Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene.

Benech P, Vigneron M, Peretz D, Revel M, Chebath J.

Mol Cell Biol. 1987 Dec;7(12):4498-504.

46.

Pulmonary capillary hemangiomatosis.

Magee F, Wright JL, Kay JM, Peretz D, Donevan R, Churg A.

Am Rev Respir Dis. 1985 Oct;132(4):922-5.

PMID:
4051326
48.

The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise.

Wright JL, Lawson L, Paré PD, Hooper RO, Peretz DI, Nelems JM, Schulzer M, Hogg JC.

Am Rev Respir Dis. 1983 Oct;128(4):702-7.

PMID:
6625346
49.

Complications of coronary arteriography.

Dodek A, Boone JA, Hooper RO, Kavanagh-Gray D, Macdonald IL, Peretz DI.

Can Med Assoc J. 1983 Apr 15;128(8):934-6.

50.

Supplemental Content

Loading ...
Support Center